Year-End Termination

CLAUDIA SCHLOSBERG for FOREST LABORATORIES INC

Period Year-End 2007 Filed Feb 2, 2008

Official filing
Firm
CLAUDIA SCHLOSBERG
Client
FOREST LABORATORIES INC
Income
$160,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 2900 Prescription Drug User Fee Authorization Act (treatment of certain enantiomer drugs; S. 1082 FDA Revitalization Act, Sec. 264 (treatment of certain enantiomer drugs; re-importation.

LobbyistCovered position, as disclosed
CLAUDIA ELLEN SCHLOSBERG N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1082 (110th), H.R. 2900 (110th)

Medicare/Medicaid MMM

H.R. 3025, Medicre Prescription Drug Savings for Our Seniors Act of 2007, Sec. 505, COverage of mental health drugs under Medicare Part D; H.R. 3162, Children's Health and Medicare Protections Act of 2007, Sec. 225, Coverage of mental health drugs under Medicare part D; S.3 Access to Critical Medications under Medicate Part D.

LobbyistCovered position, as disclosed
CLAUDIA ELLEN SCHLOSBERG N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3025 (110th), S. 3 (110th), H.R. 3162 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.